Symbol="AVTE"
AssetType="Common Stock"
Name="Aerovate Therapeutics Inc"
Description="Aerovate Therapeutics, Inc., a clinical-phase biopharmaceutical company, is focused on developing drugs that improve the lives of patients with rare cardiopulmonary diseases. The company is headquartered in Boston, Massachusetts."
CIK="1798749"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 BERKELEY STREET, FLOOR 18, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="423401000"
EBITDA="-59779000"
PERatio="None"
PEGRatio="None"
BookValue="4.557"
DividendPerShare="0"
DividendYield="0"
EPS="-2.26"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-0.415"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.548"
EVToRevenue="-"
EVToEBITDA="-10.78"
Beta="0.333"
num_52WeekHigh="30.79"
num_52WeekLow="13.81"
num_50DayMovingAverage="16.71"
num_200DayMovingAverage="20.59"
SharesOutstanding="27601100"
DividendDate="None"
ExDividendDate="None"
symbol="AVTE"
open="15.27"
high="15.74"
low="14.96"
price="15.34"
volume="60455.00"
latest_trading_day="2023-08-08"
previous_close="15.27"
change="0.07"
change_percent="0.4584%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="82951"
Change_recent_avg="-0.03"
Delta_recent_avg="1.41"
Variance_recent_avg="0.71"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_negative_thumbnail_id_2="1158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="626"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_positive_thumbnail_id_2="638"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
